The role of MGMT promotor hypermethylation as a predictive factor for response to temozolomide in recurrent high-grade glioma
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Universitair Ziekenhuis Brussel
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598978321
